Wednesday, April 18, 2018 9:01:17 AM
TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) has appointed Dr. Sam Hanna as Chief Medical Officer of its cannabis dermatology division. Dr. Hanna is a well-recognized Canadian dermatologist with experience in numerous clinical studies for dermatology drugs across North America.
https://globenewswire.com/news-release/2018/04/18/1480714/0/en/Belgravia-Appoints-Dr-Sam-Hanna-Chief-Medical-Officer-of-Cannabis-Dermatology-Division.html
GreetEat Corporation Announces Ticker Symbol Change to GEAT on OTC Markets • GEAT • Jan 14, 2025 9:40 AM
Unitronix Corp. Expands Stock Buyback Program, Reducing Outstanding Shares by Total of 165M • UTRX • Jan 14, 2025 8:14 AM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM